MedPath

Improving Biopsy Experiences Study for Women

Not Applicable
Completed
Conditions
Imaging Guided Breast Biopsy
Interventions
Behavioral: Supportive Dialogue
Behavioral: Guided Meditation
Behavioral: Music
Registration Number
NCT01811043
Lead Sponsor
Duke University
Brief Summary

The goal of this study is to examine whether a guided meditation intervention will reduce anxiety and distress as compared to a music intervention or radiologist supportive dialogue in women undergoing imaging-guided core needle breast biopsies. Both the guided meditation and music interventions are administered through use of headphones during routine outpatient imaging-guided core needle breast biopsies. Women in the guided meditation and music conditions will be given a CD with instructions for home practice. Women complete follow-up questionnaires in the 12 months after biopsy. Receipt of recommended follow-up care is examined for 60 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
243
Inclusion Criteria
  • 21 years old or older
  • Undergoing imaging guided core needle biopsy
  • Mammography or ultrasound Breast Imaging - Reporting and Data System(BI-RADS) final assessment category 3,4a-c, or 5
  • Able to speak and read English
  • Able to provide meaningful consent
Read More
Exclusion Criteria
  • significant hearing impairment
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Supportive DialogueSupportive DialogueSupportive dialogue is provided during biopsy by the radiologist performing the procedure
Guided MeditationGuided MeditationGuided meditation is played via headphones during biopsy
MusicMusicMusic is played via headphones during biopsy
Primary Outcome Measures
NameTimeMethod
Change in AnxietyChange in anxiety from baseline (i.e., pre biopsy) assessment to post biopsy assessment will be examined. Participants will be followed for the duration of the biopsy, with an expected average of 1.5 hours between assessments.

Anxiety is measured using the State Anxiety Scale of the State Trait Anxiety Inventory. Women complete this self-report measure at baseline (i.e., immediately prior to biopsy in the biopsy clinic) and immediately post-biopsy. Change in anxiety will be measured as change from baseline to post biopsy (i.e., post biopsy anxiety - baseline anxiety.) The expected duration from baseline to post biopsy assessment is expected to be an average of 1.5 hours.

Secondary Outcome Measures
NameTimeMethod
Rates of adherence to recommended follow-up care60 months following biopsy

Adherence to recommended mammography and clinical breast exam will be assessed for 60 months following biopsy. Adherence (i.e., repeated on schedule mammograms; repeated on schedule clinical breast exams) at 60 months post biopsy will be compared across study arms.

Trial Locations

Locations (1)

Duke Cancer Institute

🇺🇸

Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath